Dare Bioscience, Inc. (DARE)
NASDAQ: DARE · IEX Real-Time Price · USD
1.19
-0.04 (-3.25%)
At close: Jul 1, 2022 4:00 PM
1.18
-0.01 (-0.84%)
After-hours:
Jul 1, 2022 7:09 PM EDT
Balance Sheet (Annual)
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Year | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 - 2012 |
---|---|---|---|---|---|---|---|---|---|---|---|
Cash & Equivalents
|
51.67 | 4.67 | 4.78 | 6.81 | 7.56 | 0.04 | 75.91 | 51.17 | 5.49 | 16.71 | Upgrade
|
Cash & Cash Equivalents
|
51.67 | 4.67 | 4.78 | 6.81 | 7.56 | 0.04 | 75.91 | 51.17 | 5.49 | 16.71 | Upgrade
|
Cash Growth
|
1006.64% | -2.31% | -29.77% | -9.97% | 16845.01% | -99.94% | 48.33% | 832.47% | -67.15% | - | Upgrade
|
Receivables
|
1.15 | 0.46 | 0.56 | 0.03 | 0.28 | 0 | 1.39 | 1.66 | 0.96 | 0.36 | Upgrade
|
Other Current Assets
|
2.48 | 1.85 | 1.11 | 0.4 | 0.51 | 0 | 0 | 0 | 0 | 0 | Upgrade
|
Total Current Assets
|
55.3 | 6.98 | 6.44 | 7.24 | 8.35 | 0.04 | 77.3 | 52.84 | 6.45 | 17.06 | Upgrade
|
Property, Plant & Equipment
|
0.03 | 0.04 | 0.06 | 0.01 | 0 | 0 | 0.58 | 0.34 | 0.25 | 0.44 | Upgrade
|
Goodwill and Intangibles
|
0 | 0 | 0 | 0 | 5.19 | 0 | 0 | 0 | 0 | 0 | Upgrade
|
Other Long-Term Assets
|
0.49 | 0.53 | 0.94 | 0.58 | 0.72 | - | 0.35 | 0.22 | 0.14 | 0.16 | Upgrade
|
Total Long-Term Assets
|
0.51 | 0.57 | 1 | 0.59 | 5.91 | 0 | 0.92 | 0.56 | 0.38 | 0.6 | Upgrade
|
Total Assets
|
55.81 | 7.55 | 7.44 | 7.83 | 14.26 | 0.04 | 78.23 | 53.39 | 6.83 | 17.66 | Upgrade
|
Accounts Payable
|
2.1 | 1.02 | 1.08 | 0.46 | 0.31 | 0.01 | 2.23 | 1.26 | 0.91 | 0.9 | Upgrade
|
Deferred Revenue
|
1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | Upgrade
|
Current Debt
|
0.27 | 0.71 | 0.41 | 0 | 0 | 0.7 | 7.65 | 3.12 | 11.96 | 2.87 | Upgrade
|
Other Current Liabilities
|
12.68 | 4.92 | 4.12 | 0.63 | 0.66 | 0.05 | 6.46 | 3.68 | 2.27 | 2.76 | Upgrade
|
Total Current Liabilities
|
16.05 | 7.66 | 5.61 | 1.09 | 0.97 | 0.76 | 16.34 | 8.06 | 15.15 | 6.52 | Upgrade
|
Long-Term Debt
|
0 | 0.04 | 0.39 | 0.01 | 0 | 0 | 12.67 | 0 | 3.12 | 6.26 | Upgrade
|
Other Long-Term Liabilities
|
1 | 1 | 1 | 0 | 0 | - | 0.47 | 0.01 | 82.86 | 84.92 | Upgrade
|
Total Long-Term Liabilities
|
1 | 1.04 | 1.39 | 0.01 | 0 | 0 | 13.15 | 0.01 | 85.98 | 91.18 | Upgrade
|
Total Liabilities
|
17.05 | 8.7 | 7 | 1.1 | 0.97 | 0.76 | 29.48 | 8.07 | 101.13 | 97.7 | Upgrade
|
Total Debt
|
0.27 | 0.76 | 0.8 | 0.01 | 0 | 0.7 | 20.32 | 3.12 | 15.08 | 9.13 | Upgrade
|
Debt Growth
|
-64.25% | -5.45% | 8142.74% | - | - | -96.57% | 550.58% | -79.29% | 65.25% | - | Upgrade
|
Common Stock
|
149.04 | 70.37 | 44.57 | 35.79 | 25.54 | 0.02 | 210.12 | 167.11 | 4.14 | 1.26 | Upgrade
|
Retained Earnings
|
-110.13 | -71.43 | -44.02 | -28.97 | -12.23 | -0.73 | -161.38 | -121.78 | -98.44 | -81.3 | Upgrade
|
Comprehensive Income
|
-0.15 | -0.09 | -0.1 | -0.1 | -0.02 | 0 | 0 | 0 | 0 | 0 | Upgrade
|
Shareholders' Equity
|
38.75 | -1.15 | 0.44 | 6.73 | 13.29 | -0.71 | 48.74 | 45.33 | -94.3 | -80.04 | Upgrade
|
Total Liabilities and Equity
|
55.81 | 7.55 | 7.44 | 7.83 | 14.26 | 0.04 | 78.23 | 53.39 | 6.83 | 17.66 | Upgrade
|
Net Cash / Debt
|
51.4 | 3.91 | 3.98 | 6.8 | 7.56 | -0.65 | 55.58 | 48.05 | -9.59 | 7.58 | Upgrade
|
Net Cash / Debt Growth
|
1213.79% | -1.68% | -41.44% | -10.10% | - | - | 15.68% | - | - | - | Upgrade
|
Net Cash Per Share
|
0.84 | 0.13 | 0.26 | 0.63 | 2.34 | -0.78 | 21.86 | 33.03 | -140.20 | 124.40 | Upgrade
|
Working Capital
|
39.24 | -0.68 | 0.83 | 6.15 | 7.38 | -0.71 | 60.97 | 44.78 | -8.7 | 10.54 | Upgrade
|
Book Value Per Share
|
0.63 | -0.04 | 0.03 | 0.63 | 4.11 | -0.85 | 19.17 | 31.15 | -1.00 | -1.00 | Upgrade
|
Source: Financials are provided by
Nasdaq Data Link
and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).